The main purpose of this study is to find out if the experimental drug roxadustat (also known as FG-4592) is safe and effective for potentially treating anemia in people receiving chemotherapy treatments for cancer.
In order to take part in this study, participant must have anemia (as confirmed
by a blood test), and must have received a few chemotherapy treatments,
which the study doctor thinks is the cause of anemia. Participant must also
meet other study requirements to qualify for the study.
Study Identifier: 834078
Contact the research team to learn more about this study.